Income StatementBalance SheetCash FlowSegments
STERIS logo

STERIS Business Segments

Business, geographic, and product segment breakdowns

STERIS generates $5.8B in annual revenue across 3 key segments: Applied Sterilization Technologies ($549.4M), Healthcare ($2.4B), and Life Sciences: ($65.6M). The company-wide operating margin is 17.18%. Based on the Q4 2025 filing.

Applied Sterilization Technologies (TTM)$549.4MHealthcare (TTM)$2.4BLife Sciences:$65.6M
Latest FilingQ4 2025
Report Date2026-02-06
Market Cap$20.9B
P/E Ratio29.49
ROE10.43%

Products & Services

Revenue

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Consumables$413.8M$426.9M$428.8M$434.2M$451.4M$463.0M
Capital equipment$281.5M$290.9M$371.0M$255.5M$293.4M$315.6M

Cost of Product and Service Sold

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Service$381.4M$388.5M$405.9M$403.4M$423.6M$422.5M
Product$368.7M$371.7M$433.4M$359.7M$390.8M$418.2M

Total revenues

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Service$633.5M$652.7M$680.7M$701.4M$715.3M$717.6M

Geographic

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Property, Plant and Equipment, Net——$872.9M——$967.8M
Revenue—$343.9M———$382.3M
Valuation Allowance, Deferred Tax Asset, Change in Amount$1.5M$1.5M$1.5M———

Business Segments

Total Assets

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Applied Sterilization Technologies——$3.3B$3.5B$3.5B$3.6B

Cost of Revenue

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Healthcare$541.5M$552.4M$599.2M$557.4M$592.1M$615.6M
Applied Sterilization Technologies$134.1M$127.9M$138.8M$129.9M$139.6M$141.1M
Life Sciences:$57.4M$60.9M——$66.4M$65.6M

Depreciation, Depletion and Amortization

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Applied Sterilization Technologies$34.6M$38.4M$36.5M$36.3M$38.9M$40.0M

Operating Income (Loss), Before Adjustments

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Healthcare$228.0M$246.9M$279.7M$235.5M$259.5M$258.1M
Applied Sterilization Technologies$109.9M$115.8M$122.2M$136.7M$127.7M$129.2M
Life Sciences:—$58.1M———$61.8M

Payments to Acquire Productive Assets

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Applied Sterilization Technologies$54.2M$63.9M$45.7M$49.2M$74.1M$55.7M

R&D

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Healthcare$23.7M$23.2M$23.7M$22.7M$24.3M$25.2M
Life Sciences:$2.1M$2.4M——$2.7M$2.8M
Applied Sterilization Technologies$900.0K$1.2M$1.1M$900.0K$700.0K$800.0K

Revenue

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Healthcare$944.3M$976.0M$1.1B$974.7M$1.0B$1.1B
Applied Sterilization Technologies$256.7M$258.1M$273.9M$281.2M$281.5M$286.6M
Life Sciences:$127.9M$136.4M——$145.0M$145.8M

Segment operating income

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Segment operating income$294.5M$320.0M——$337.1M$343.1M
Healthcare—$246.9M———$258.1M
Applied Sterilization Technologies$109.9M$115.8M——$127.6M$129.2M
Corporate-$97.1M-$100.8M——-$109.9M-$106.0M
Life Sciences:$53.7M$58.1M——$59.9M$61.8M

Selling, general, and administrative

SegmentQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Healthcare$151.0M$153.5M$154.6M$159.1M$157.9M$164.8M
Life Sciences:$14.7M$15.0M——$16.1M$15.6M
Applied Sterilization Technologies$11.8M$13.3M$11.9M$13.7M$13.5M$15.4M